• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gene therapy for ALI/ARDS.基因治疗急性肺损伤/急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):705-18. doi: 10.1016/j.ccc.2011.04.002.
2
Clinical review: gene-based therapies for ALI/ARDS: where are we now?临床综述:急性肺损伤/急性呼吸窘迫综合征的基因治疗:我们现在在哪里?
Crit Care. 2011;15(3):224. doi: 10.1186/cc10216. Epub 2011 Jun 20.
3
Novel interventional approaches for ALI/ARDS: cell-based gene therapy.新型 ALI/ARDS 介入治疗方法:细胞基因治疗。
Mediators Inflamm. 2011;2011:560194. doi: 10.1155/2011/560194. Epub 2011 Jul 13.
4
Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.间充质干细胞在急性肺损伤/急性呼吸窘迫综合征中的治疗意义
Stem Cell Res Ther. 2013 May 2;4(3):45. doi: 10.1186/scrt193.
5
Surfactant therapy for acute lung injury and acute respiratory distress syndrome.表面活性物质治疗急性肺损伤和急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):525-59. doi: 10.1016/j.ccc.2011.04.005.
6
Advances in the use of exosomes for the treatment of ALI/ARDS.外泌体在治疗 ALI/ARDS 中的应用进展。
Front Immunol. 2022 Aug 9;13:971189. doi: 10.3389/fimmu.2022.971189. eCollection 2022.
7
Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment.急性肺损伤与急性呼吸窘迫综合征:病理生理学与治疗
Mo Med. 2010 Jul-Aug;107(4):252-8.
8
Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome.针对 MALAT1 和 miRNA-181a-5p 干预急性肺损伤/急性呼吸窘迫综合征。
Respir Med. 2020 Dec;175:106210. doi: 10.1016/j.rmed.2020.106210. Epub 2020 Nov 4.
9
Upregulation of alveolar fluid clearance is not sufficient for Na,K-ATPase β subunit-mediated gene therapy of LPS-induced acute lung injury in mice.肺泡液体清除的上调不足以实现 Na,K-ATPase β 亚基介导的脂多糖诱导的急性肺损伤的基因治疗在小鼠中。
Sci Rep. 2023 Apr 26;13(1):6792. doi: 10.1038/s41598-023-33985-4.
10
Management of acute lung injury/ARDS.急性肺损伤/急性呼吸窘迫综合征的管理
Indian J Pediatr. 2010 Nov;77(11):1296-302. doi: 10.1007/s12098-010-0169-z. Epub 2010 Sep 4.

引用本文的文献

1
Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.肽序列对环状两亲肽给药载体功能性 siRNA 递呈和基因敲低的影响。
Mol Pharm. 2023 Dec 4;20(12):6090-6103. doi: 10.1021/acs.molpharmaceut.3c00455. Epub 2023 Nov 14.
2
Lianhua Qingke ameliorates lipopolysaccharide-induced lung injury by inhibiting neutrophil extracellular traps formation and pyroptosis.连花清咳通过抑制中性粒细胞胞外诱捕网形成和细胞焦亡改善脂多糖诱导的肺损伤。
Pulm Circ. 2023 Oct 6;13(4):e12295. doi: 10.1002/pul2.12295. eCollection 2023 Oct.
3
THE CRITICAL ROLE OF THE HISTONE MODIFICATION ENZYME SETDB2 IN THE PATHOGENESIS OF ACUTE RESPIRATORY DISTRESS SYNDROME.组蛋白修饰酶 SETDB2 在急性呼吸窘迫综合征发病机制中的关键作用。
Shock. 2023 Jul 1;60(1):137-145. doi: 10.1097/SHK.0000000000002145. Epub 2023 Jun 1.
4
The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs.谷胱甘肽介导的聚乙二醇化青蒿琥酯前药减轻脂多糖诱导的小鼠急性肺损伤
Front Pharmacol. 2022 May 20;13:860492. doi: 10.3389/fphar.2022.860492. eCollection 2022.
5
Gene Therapy for Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的基因治疗
Front Physiol. 2022 Jan 17;12:786255. doi: 10.3389/fphys.2021.786255. eCollection 2021.
6
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.针对急性肺损伤/急性呼吸窘迫综合征的小干扰RNA的肺部递送
Acta Pharm Sin B. 2022 Feb;12(2):600-620. doi: 10.1016/j.apsb.2021.08.009. Epub 2021 Aug 12.
7
Nanomedicine-Based Therapeutics to Combat Acute Lung Injury.基于纳米医学的治疗方法对抗急性肺损伤。
Int J Nanomedicine. 2021 Mar 18;16:2247-2269. doi: 10.2147/IJN.S300594. eCollection 2021.
8
Acetylharpagide Protects Mice from -Induced Acute Lung Injury by Inhibiting NF-κB Signaling Pathway.乙酰哈巴苷通过抑制 NF-κB 信号通路保护小鼠免受 LPS 诱导的急性肺损伤。
Molecules. 2020 Nov 25;25(23):5523. doi: 10.3390/molecules25235523.
9
RNAi therapeutic strategies for acute respiratory distress syndrome.急性呼吸窘迫综合征的 RNAi 治疗策略。
Transl Res. 2019 Dec;214:30-49. doi: 10.1016/j.trsl.2019.07.011. Epub 2019 Jul 27.
10
[The Use Of Pulmonary Gene Therapy In The Treatment Of Experimental Models Of Pneumonia And Septicemia].[肺部基因疗法在肺炎和败血症实验模型治疗中的应用]
Gac Med Caracas. 2018 Mar;126(1):5-14.

本文引用的文献

1
IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.AAV5 载体递送的 IL-10 可减轻铜绿假单胞菌肺炎小鼠的炎症反应。
Gene Ther. 2010 May;17(5):567-76. doi: 10.1038/gt.2010.28. Epub 2010 Apr 1.
2
Progress and prospects: nuclear import of nonviral vectors.进展与展望:非病毒载体的核导入。
Gene Ther. 2010 Apr;17(4):439-47. doi: 10.1038/gt.2010.31. Epub 2010 Mar 4.
3
Administration of nonviral gene vector encoding rat beta-defensin-2 ameliorates chronic Pseudomonas aeruginosa lung infection in rats.给予编码大鼠β-防御素-2 的非病毒基因载体可改善大鼠慢性铜绿假单胞菌肺部感染。
J Gene Med. 2010 Mar;12(3):276-86. doi: 10.1002/jgm.1435.
4
The SP-C promoter facilitates alveolar type II epithelial cell-specific plasmid nuclear import and gene expression.SP-C 启动子促进肺泡 II 型上皮细胞特异性质粒核导入和基因表达。
Gene Ther. 2010 Apr;17(4):541-9. doi: 10.1038/gt.2009.166. Epub 2010 Jan 7.
5
Vectors for pulmonary gene therapy.肺部基因治疗载体。
Int J Pharm. 2010 May 5;390(1):84-8. doi: 10.1016/j.ijpharm.2009.10.010. Epub 2009 Oct 13.
6
Tissue-specific and transcription factor-mediated nuclear entry of DNA.组织特异性及转录因子介导的DNA核内导入
Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):603-13. doi: 10.1016/j.addr.2009.02.008. Epub 2009 Apr 23.
7
Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.内源性4-1BB配体在预防流感诱发疾病中起关键作用。
J Immunol. 2009 Jan 15;182(2):934-47. doi: 10.4049/jimmunol.182.2.934.
8
Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer.用于黑色素瘤和乳腺癌患者非病毒瘤内基因转移的新型喷射注射技术。
Clin Cancer Res. 2008 Nov 15;14(22):7545-53. doi: 10.1158/1078-0432.CCR-08-0412.
9
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.急性肺损伤和急性呼吸窘迫综合征的药物治疗
Curr Med Chem. 2008;15(19):1911-24. doi: 10.2174/092986708785132942.
10
Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice.基因枪介导的DNA疫苗接种在非肥胖糖尿病小鼠1型糖尿病临床前晚期增强了抗原特异性免疫治疗。
Clin Immunol. 2008 Oct;129(1):49-57. doi: 10.1016/j.clim.2008.06.001.

基因治疗急性肺损伤/急性呼吸窘迫综合征。

Gene therapy for ALI/ARDS.

机构信息

Department of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA.

出版信息

Crit Care Clin. 2011 Jul;27(3):705-18. doi: 10.1016/j.ccc.2011.04.002.

DOI:10.1016/j.ccc.2011.04.002
PMID:21742224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3482940/
Abstract

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by acute respiratory failure and are associated with diverse disorders. Gene therapy is a potentially powerful approach to treat diseases related to ALI/ARDS, and numerous viral and nonviral methods for gene delivery to the lung have been developed. Discussed are recent advances in the development of more efficient viral and nonviral gene transfer systems, and the current status of gene therapy applied to ALI/ARDS-associated pulmonary diseases is reviewed. With the development of more efficient gene therapy vectors, gene therapy is a promising strategy for clinical application.

摘要

急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)的特征是急性呼吸衰竭,并与多种疾病有关。基因治疗是治疗与 ALI/ARDS 相关疾病的一种潜在强大方法,已经开发出许多用于将基因递送到肺部的病毒和非病毒方法。本文讨论了开发更有效的病毒和非病毒基因转移系统的最新进展,并综述了基因治疗在与 ALI/ARDS 相关的肺部疾病中的应用现状。随着更有效的基因治疗载体的发展,基因治疗是一种很有前途的临床应用策略。